Talazoparib tosylate
| Talazoparib tosylate | |
|---|---|
| Term | Talazoparib tosylate |
| Short definition | Talazoparib tosylate - (pronounced) (TA-luh-ZOH-puh-rib TOH-suh-layt) A drug used to treat adults with HER2-negative breast cancer that is locally advanced or has spread and has certain mutations (changes) in the BRCA1 or BRCA2 gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Talazoparib tosylate - (pronounced) (TA-luh-ZOH-puh-rib TOH-suh-layt) A drug used to treat adults with HER2-negative breast cancer that is locally advanced or has spread and has certain mutations (changes) in the BRCA1 or BRCA2 gene. It is also being studied in the treatment of other types of cancer. Talazoparib tosylate blocks an enzyme involved in many cell functions, including repairing DNA damage. Blocking this enzyme can help prevent cancer cells from repairing their damaged DNA, causing them to die. Talazoparib tosylate is a type of PARP inhibitor. Also called Talzenna
External links
- Medical encyclopedia article on Talazoparib tosylate
- Wikipedia's article - Talazoparib tosylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski